Abstract

Dental-derived mesenchymal stem cells (MSCs) provide an advantageous therapeutic option for tissue engineering due to their high accessibility and bioavailability. However, delivering MSCs to defect sites while maintaining a high MSC survival rate is still a critical challenge in MSC-mediated tissue regeneration. Here, we tested the osteogenic and adipogenic differentiation capacity of dental pulp stem cells (DPSCs) in a thermoreversible Pluronic F127 hydrogel scaffold encapsulation system in vitro. DPSCs were encapsulated in Pluronic® F-127 hydrogel and stem cell viability, proliferation and differentiation into adipogenic and osteogenic tissues were evaluated. The degradation profile and swelling kinetics of the hydrogel were also analyzed. Our results confirmed that Pluronic F-127 is a promising and non-toxic scaffold for encapsulation of DPSCs as well as control human bone marrow MSCs (hBMMSCs), yielding high stem cell viability and proliferation. Moreover, after 2 weeks of differentiation in vitro, DPSCs as well as hBMMSCs exhibited high levels of mRNA expression for osteogenic and adipogenic gene markers via PCR analysis. Our histochemical staining further confirmed the ability of Pluronic F-127 to direct the differentiation of these stem cells into osteogenic and adipogenic tissues. Furthermore, our results revealed that Pluronic F-127 has a dense tubular and reticular network morphology, which contributes to its high permeability and solubility, consistent with its high degradability in the tested conditions. Altogether, our findings demonstrate that Pluronic F-127 is a promising scaffold for encapsulation of DPSCs and can be considered for cell delivery purposes in tissue engineering.

Highlights

  • Mesenchymal stem cells (MSCs) present an advantageous treatment option where tissue regeneration is required, in comparison to traditional treatment modalities available in medicine and dentistry

  • Our data confirmed that dental pulp stem cells (DPSCs) formed significantly higher numbers of single-colony clusters (CFU-F) than human bone marrow MSCs (hBMMSCs) (Fig. 1a)

  • No significant difference in the amount of adipogenic tissue was observed between DPSCs and hBMMSCs (P [ 0.05) (Fig. 3d)

Read more

Summary

Introduction

Mesenchymal stem cells (MSCs) present an advantageous treatment option where tissue regeneration is required, in comparison to traditional treatment modalities available in medicine and dentistry. Besides the amount of tissue available may be modest, autograft harvesting is associated with increased patient pain and high risk of donor site morbidity [1]. Studies have confirmed that MSC-based tissue regeneration strategies offer advantages including the avoidance of donor-site harvesting and associated morbidity, high-quality regeneration of damaged tissues, and low risk of disease transmission or autoimmune rejection [2,3,4]. Our previous studies and others have shown that dental MSCs are proliferative postnatal stem cells capable of differentiating into odontogenic, adipogenic, and osteogenic tissues [11,12,13,14,15,16]. It has been reported that these MSCs might have

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call